Back

Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs

EP Europace Journal

16 October 2024
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE

Contributors

Meye Bloothooft
Meye Bloothooft

Author

Niels Voigt
Niels Voigt

Author

Institute of Pharmacology and Toxicology, University Medical Center Goettingen Goettingen , Germany

Teun P de Boer
Teun P de Boer

Author

University Medical Center Utrecht Utrecht , Netherlands (The)

You may be interested in
thumbnail
Congress Presentation
The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs
3 April 2022
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Webinar
Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management
10 June 2021
thumbnail
Congress Presentation
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-center experience
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources